1. Home
  2. KYMR vs ABM Comparison

KYMR vs ABM Comparison

Compare KYMR & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • ABM
  • Stock Information
  • Founded
  • KYMR 2015
  • ABM 1909
  • Country
  • KYMR United States
  • ABM United States
  • Employees
  • KYMR N/A
  • ABM N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • ABM Diversified Commercial Services
  • Sector
  • KYMR Health Care
  • ABM Finance
  • Exchange
  • KYMR Nasdaq
  • ABM Nasdaq
  • Market Cap
  • KYMR 3.0B
  • ABM 3.5B
  • IPO Year
  • KYMR 2020
  • ABM N/A
  • Fundamental
  • Price
  • KYMR $41.96
  • ABM $55.00
  • Analyst Decision
  • KYMR Buy
  • ABM Hold
  • Analyst Count
  • KYMR 13
  • ABM 3
  • Target Price
  • KYMR $51.15
  • ABM $55.33
  • AVG Volume (30 Days)
  • KYMR 415.6K
  • ABM 361.9K
  • Earning Date
  • KYMR 10-31-2024
  • ABM 12-11-2024
  • Dividend Yield
  • KYMR N/A
  • ABM 1.64%
  • EPS Growth
  • KYMR N/A
  • ABM N/A
  • EPS
  • KYMR N/A
  • ABM 2.43
  • Revenue
  • KYMR $87,563,000.00
  • ABM $8,274,900,000.00
  • Revenue This Year
  • KYMR N/A
  • ABM $3.00
  • Revenue Next Year
  • KYMR $21.47
  • ABM $1.31
  • P/E Ratio
  • KYMR N/A
  • ABM $22.65
  • Revenue Growth
  • KYMR 86.92
  • ABM 3.25
  • 52 Week Low
  • KYMR $17.89
  • ABM $39.64
  • 52 Week High
  • KYMR $53.27
  • ABM $59.78
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 34.56
  • ABM 50.82
  • Support Level
  • KYMR $45.16
  • ABM $52.85
  • Resistance Level
  • KYMR $53.23
  • ABM $59.15
  • Average True Range (ATR)
  • KYMR 2.58
  • ABM 1.11
  • MACD
  • KYMR -0.54
  • ABM 0.01
  • Stochastic Oscillator
  • KYMR 1.66
  • ABM 34.13

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

Share on Social Networks: